Correction: Systematic review and metaanalysis comparing zoledronic acid administered at 12week and 4week intervals in patients with bone metastasis

Ling Cao^1,*, Yong-Jing Yang^1,*, Jian-Dong Diao², Xu-He Zhang¹, Yan-Ling Liu¹, Bo-Yu Wang¹, Zhi-Wen Li³ and Shi-Xin Liu¹

¹ Department of Radiation Oncology, Cancer Hospital of Jilin Province, Changchun 130012, People’s Republic of China
² Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun 130012, People’s Republic of China
³ Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin, 130021, People’s Republic of China
^* These authors contributed equally to this work

Published: August 14, 2018

This article has been corrected: The correct affiliation is given below:

² Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun 130012, People’s Republic of China

Original article: Oncotarget. 2017; 8:90308-90314. DOI: https://doi.org/10.18632/oncotarget.19856.